Nicotinamide Mononucleotide Ameliorates Nano‐Aluminum Oxide‐Induced Cognitive Impairment and Ferroptosis via the GSH/GPX4 Axis
Small · 2026-06 · 22 (36)
DOI: 10.1002/smll.202508100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 08.05.2026. Verfasst von Lei Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory of Sir Run Run Shaw Hospital and School of Public Health, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Glutathione, Ferroptosis, Cognitive Dysfunction, Aluminum Oxide. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Medical and Health Research Project of Zhejiang Province by the Health Commission of Zhejiang.
Abstract (Originalsprache)
Aluminum oxide nanoparticles (Nano‐Al 2 O 3 ) are widely used engineered nanomaterials, but their neurotoxic effects and underlying mechanisms remain incompletely understood. Nicotinamide mononucleotide (NMN), a precursor to nicotinamide adenine dinucleotide (NAD), possesses antioxidant properties and neuroprotective potential. In this study, we investigated whether NMN mitigates Nano‐Al 2 O 3 ‐induced cognitive impairment and neuronal injury, with a focus on ferroptosis‐related pathways. Behavioral tests demonstrated that Nano‐Al 2 O 3 exposure impaired learning and memory in mice. Histological and ultrastructural analyses revealed hippocampal neuronal loss, reduced Nissl body density, and mitochondrial abnormalities, all of which were alleviated by NMN treatment. Nano‐Al 2 O 3 exposure also increased lipid peroxidation, malondialdehyde, Fe 2+ , and reactive oxygen species, while decreasing NAD + , glutathione (GSH), and glutathione peroxidase 4 (GPX4), indicating ferroptosis‐related damage. NMN largely reversed these alterations, restored redox homeostasis, and improved cognitive performance. Collectively, these findings suggest that Nano‐Al 2 O 3 ‐induced neurotoxicity is associated with dysregulation of the GSH/GPX4 axis and that NMN protects against cognitive impairment and neuronal injury, at least in part, by suppressing ferroptosis‐related processes. These findings suggest that Nano‐Al 2 O 3 ‐induced neurotoxicity is associated with dysregulation of the GSH/GPX4 axis and that NMN protects against cognitive impairment and neuronal injury, at least in part, by suppressing ferroptosis‐related processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory of Sir Run Run Shaw Hospital and School of Public Health, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Occupational Health and Radiation Protection, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
- Genetic Lab, Shaoxing Maternity and Child Health Hospital, Shaoxing, China.
- Changxing County Center For Disease Control and Prevention, Huzhou, China.
- Changxing Hospital, Zhejiang Medical & Health Group, Huzhou, China.
ORCID-Profile: Xiangjing Gao, Xiangwei Gao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Medical and Health Research Project of Zhejiang Province by the Health Commission of Zhejiang
Zitieren
APA
Yu, L., Zhang, T., Lou, X., Zou, H., Xie, H., Yan, F., Ran, Q., Zhou, L., Gao, X., Hu, Y., & Gao, X. (2026). Nicotinamide Mononucleotide Ameliorates Nano‐Aluminum Oxide‐Induced Cognitive Impairment and Ferroptosis via the GSH/GPX4 Axis. Small, 22(36). https://doi.org/10.1002/smll.202508100
Vancouver
Yu L, Zhang T, Lou X, Zou H, Xie H, Yan F, et al. Nicotinamide Mononucleotide Ameliorates Nano‐Aluminum Oxide‐Induced Cognitive Impairment and Ferroptosis via the GSH/GPX4 Axis. Small. 2026;22(36). doi:10.1002/smll.202508100
BibTeX
@article{Yu2026,
author = {Yu, Lei and Zhang, Tao and Lou, Xiaoming and Zou, Hua and Xie, Hongwei and Yan, Fu and Ran, Qingxue and Zhou, Lifang and Gao, Xiangjing and Hu, Yong and Gao, Xiangwei},
title = {Nicotinamide Mononucleotide Ameliorates Nano‐Aluminum Oxide‐Induced Cognitive Impairment and Ferroptosis via the GSH/GPX4 Axis},
journal = {Small},
year = {2026},
volume = {22},
number = {36},
doi = {10.1002/smll.202508100}
}
EUVIMED